Our findings provide a comprehensive understanding of the molecular mechanisms through which exosomal LYPLAL1-DT facilitates crosstalk between tumor cells and endothelial cells, promoting malignant phenotypes and vascular remodeling in SCLC. The gene discussed is LYPLAL1; the disease is small cell lung carcinoma.